In contrast to the effect of TGFβ in combination with the K562 feeder cells, IL-2 plus TGFβ alone did not enhance the anti-tumor IFNγ and TNFα production, in agreement with what has been previously reported (Figure 2B). The gene discussed is TNF; the disease is neoplasm.